The fastest-growing and largest of the 26 sized Medical Devices markets in the Philippines, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Anesthesia Monitoring Devices | $6 Mn | $20 Mn | 13% | 0 |
| 2 | Aesthetic Lasers and Energy Devices | $4 Mn | $12 Mn | 12.6% | 1 |
| 3 | Insulin Patch Pumps | $2 Mn | $6 Mn | 12.5% | 0 |
| 4 | Dental Caries Detectors | $1 Mn | $3 Mn | 12.3% | 0 |
| 5 | Anesthesia & Respiratory Devices | $63 Mn | $164 Mn | 10% | 0 |
| 6 | Air Ambulance Life Support Solutions | $10 Mn | $25 Mn | 9.6% | 0 |
| 7 | Anti-Snoring Devices | $3 Mn | $7 Mn | 9.3% | 0 |
| 8 | Advanced Bipolar Direct Energy Devices | $7 Mn | $16 Mn | 9.2% | 0 |
| 9 | Acute Care Needleless Connectors | $1 Mn | $2 Mn | 8% | 0 |
| 10 | Disposable Surgical Devices | $20 Mn | $42 Mn | 7.8% | 26 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Diabetes Care Devices | $94 Mn | $174 Mn | 6.4% | 1 |
| 2 | Anesthesia & Respiratory Devices | $63 Mn | $164 Mn | 10% | 0 |
| 3 | Rehabilitation Equipments | $44 Mn | $83 Mn | 6.6% | 1 |
| 4 | Defibrillator | $39 Mn | $73 Mn | 6.4% | 1 |
| 5 | Insulin Delivery Devices | $35 Mn | $69 Mn | 7% | 0 |
| 6 | Angiography Devices | $27 Mn | $53 Mn | 6.8% | 1 |
| 7 | Dental Diagnostic and Surgical Equipments | $26 Mn | $55 Mn | 7.6% | 12 |
| 8 | Direct Energy Medical Devices | $24 Mn | $42 Mn | 5.5% | 0 |
| 9 | Disposable Surgical Devices | $20 Mn | $42 Mn | 7.8% | 26 |
| 10 | Audiology Devices | $17 Mn | $34 Mn | 6.9% | 0 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Anesthesia Monitoring Devices grows fastest, at 13% a year from 2023 to 2033, ahead of Aesthetic Lasers and Energy Devices (12.6%).
Diabetes Care Devices is the largest, worth about $94 Mn in 2023 and $174 Mn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.